This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Universitè Laval. Active years: 2009-2022.
Location History:
- Cap-Rouge, CA (2009)
- Montréal, CA (2009 - 2022)
Company Filing History:
Years Active: 2009-2022
Title: **Innovative Contributions of Philippe A Tessier in Biomedical Patents**
Introduction
Philippe A Tessier, an accomplished inventor based in Cap-Rouge, CA, has made significant strides in the field of biomedical research. With a remarkable portfolio of five patents, Tessier has contributed to innovative solutions aimed at addressing critical health issues.
Latest Patents
Among his notable inventions, Tessier's latest patents include a humanized anti-S100A9 antibody and its applications. This invention focuses on an inhibitor of Toll-like Receptor 2 (TLR2), which specifically blocks the interaction between S100A9 and TLR2, presenting a promising avenue for treating inflammatory conditions in human patients. Furthermore, he has developed an anti-S100A8 antibody aimed at treating leukemia. This particular invention binds specifically to a portion of the S100A8 protein and/or a S100A8/S100A9 heterodimer, opening new possibilities for leukemia therapies.
Career Highlights
Philippe A Tessier has collaborated with esteemed institutions such as Université Laval, where he has contributed to groundbreaking research and innovation. His work has underscored the importance of targeted therapies in the realm of human health and disease treatment.
Collaborations
Throughout his career, Tessier has worked alongside prominent coworkers, including Carle Ryckman and Karen Vandal. These collaborations have facilitated the advancement of his research and the development of his patents, highlighting the collaborative nature of scientific innovation.
Conclusion
Philippe A Tessier stands out as a notable inventor in the biomedical field, with patents that have the potential to make a significant impact on health care. His contributions not only reflect his expertise but also the importance of continued innovation in the treatment of complex medical conditions.